tiprankstipranks
Trending News
More News >
Vitasoy International Holdings Limited (HK:0345)
:0345
Advertisement

Vitasoy International Holdings (0345) AI Stock Analysis

Compare
12 Followers

Top Page

HK:0345

Vitasoy International Holdings

(OTC:0345)

Rating:66Neutral
Price Target:
HK$10.00
▲(4.71% Upside)
Vitasoy International Holdings' overall stock score is primarily driven by its solid financial performance, with strong revenue growth and improved margins. However, the technical analysis indicates a lack of upward momentum, and the valuation suggests the stock may be overvalued. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Earnings
Vitasoy reported a 102% year-over-year increase in earnings, highlighting a strong financial performance.
Operating Profit
Improvement in operating profit across core regions such as China and Hong Kong and reduction in operating losses in Australia are key drivers for growth.
Negative Factors
China Market
Maintaining a conservative outlook on Vitasoy's prospects in China as competition remains fierce, especially in the sugar-free tea category.
Competitive Landscape
Softer prospects in China due to an intense competitive landscape may impact Vitasoy's market position.

Vitasoy International Holdings (0345) vs. iShares MSCI Hong Kong ETF (EWH)

Vitasoy International Holdings Business Overview & Revenue Model

Company DescriptionVitasoy International Holdings Limited, together with its subsidiaries, manufactures and sells food and beverages in Mainland China, Hong Kong, Australia, New Zealand, and Singapore. It offers soya milk and other plant milk products, tea, water, juice, tofu, etc. The company also operates tuck shops and catering business; sells beverages; and exports soya related products, as well as invests in properties. It sells its products through distributors and retailers. The company was incorporated in 1940 and is based in Tuen Mun, Hong Kong.
How the Company Makes MoneyVitasoy generates revenue primarily through the sale of its plant-based products, which include soy milk, tofu, and other food items. The company has established a robust distribution network that includes supermarkets, convenience stores, and online platforms, allowing it to reach a wide customer base. Key revenue streams include both domestic sales in Hong Kong and international sales across markets like mainland China, Australia, and other regions. In addition to direct product sales, Vitasoy benefits from strategic partnerships with retailers and distributors that enhance market penetration. The company also invests in marketing and brand development to increase consumer awareness and drive sales in the competitive plant-based market.

Vitasoy International Holdings Financial Statement Overview

Summary
Vitasoy International Holdings demonstrates mixed financial performance. While the income statement shows declining revenue and low net profit margins, the balance sheet and cash flow statement reveal improving leverage metrics and strong cash flow generation. The company is managing costs effectively, but needs to focus on revenue growth and operational efficiency to enhance profitability.
Income Statement
65
Positive
Vitasoy's revenue has shown a declining trend over the past few years, with a decrease from HKD 7.52 billion in 2021 to HKD 6.22 billion in 2024. The gross profit margin improved from 44.5% in 2023 to 49.9% in 2024, indicating better cost management. However, net profit margin has been volatile, recovering to 1.87% in 2024 from a low of -2.44% in 2022. EBIT margin remains relatively low at 2.98% for 2024, reflecting a need for operational efficiency improvements.
Balance Sheet
70
Positive
The company's balance sheet shows moderate leverage with a debt-to-equity ratio of 0.19 in 2024, down from 0.22 in 2023, indicating a reduction in reliance on debt. Return on equity improved to 3.87% in 2024 from 1.53% in 2023, suggesting enhanced profitability. The equity ratio of 53.3% in 2024 reflects a strong equity base, providing stability and reducing financial risk.
Cash Flow
75
Positive
The cash flow statement highlights significant growth in free cash flow from HKD 300 million in 2023 to HKD 644 million in 2024, indicating improved cash generation. The operating cash flow to net income ratio is robust at 6.79 in 2024, showing strong cash generation relative to net income. The free cash flow to net income ratio is also strong at 5.54, underscoring efficient cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.27B6.27B6.22B6.34B6.50B7.52B
Gross Profit3.16B3.22B3.10B2.82B3.07B3.95B
EBITDA689.50M860.30M601.23M619.28M346.77M1.29B
Net Income124.20M234.67M116.37M45.72M-158.75M548.35M
Balance Sheet
Total Assets6.08B5.65B5.64B5.85B6.81B7.28B
Cash, Cash Equivalents and Short-Term Investments1.34B1.27B794.45M555.29M621.86M970.52M
Total Debt685.58M563.65M558.85M660.87M677.59M335.74M
Total Liabilities2.81B2.47B2.52B2.75B3.24B3.32B
Stockholders Equity3.16B3.08B3.00B2.98B3.26B3.62B
Cash Flow
Free Cash Flow681.26M734.33M644.25M300.21M-295.70M617.89M
Operating Cash Flow824.07M859.02M790.54M487.68M113.17M1.26B
Investing Cash Flow-148.48M65.89M-317.52M-481.79M-405.82M-641.86M
Financing Cash Flow-65.07M-298.24M-403.49M-58.95M-68.05M-548.78M

Vitasoy International Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price9.55
Price Trends
50DMA
9.35
Negative
100DMA
9.55
Negative
200DMA
9.59
Negative
Market Momentum
MACD
-0.02
Negative
RSI
49.01
Neutral
STOCH
57.25
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0345, the sentiment is Negative. The current price of 9.55 is above the 20-day moving average (MA) of 9.31, above the 50-day MA of 9.35, and below the 200-day MA of 9.59, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 49.01 is Neutral, neither overbought nor oversold. The STOCH value of 57.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0345.

Vitasoy International Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$9.98B42.427.71%1.11%0.91%101.66%
63
Neutral
$21.01B14.53-7.26%3.13%3.36%-7.91%
$964.65M20.91-0.91%3.56%
71
Outperform
HK$7.23B37.465.15%1.39%3.95%-42.81%
71
Outperform
HK$13.01B16.2315.77%5.46%4.68%-14.34%
67
Neutral
HK$14.34B36.79
2.35%
62
Neutral
HK$8.48B14.525.82%38.41%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0345
Vitasoy International Holdings
9.55
4.35
83.51%
BTSDF
Health and Happiness (H&H) International Holdings
1.16
-0.09
-7.20%
HK:1475
Nissin Foods Co., Ltd.
6.89
2.73
65.62%
HK:1579
Yihai International Holding Ltd.
13.50
2.83
26.52%
HK:1610
COFCO Joycome Foods Limited
1.84
0.25
15.72%
HK:9676
Shiyue Daotian Group Co., Ltd Class H
7.73
-12.22
-61.25%

Vitasoy International Holdings Corporate Events

Vitasoy Announces AGM with Key Resolutions on Financials and Share Mandates
Jul 17, 2025

Vitasoy International Holdings Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for August 25, 2025, where key agenda items include the adoption of financial statements, approval of a final dividend, re-election of directors, and appointment of auditors. Additionally, the company seeks shareholder approval for general mandates to issue and buy-back shares, which could influence its capital structure and market operations.

The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Vitasoy Announces Share Option Grants Requiring Shareholder Approval
Jul 11, 2025

Vitasoy International Holdings announced a supplemental update regarding the grant of share options and performance share units to its executives and employees. The grant includes 1,326,000 share options to the Executive Chairman, Mr. Winston Yau-lai Lo, which represents 0.12% of the company’s shares as of June 2025. This grant is subject to approval by independent shareholders at the 2025 AGM, as it exceeds the threshold set by the Listing Rules. The company plans to distribute a circular with more details to shareholders.

The most recent analyst rating on (HK:0345) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Vitasoy Grants Share Options to Align Employee Interests with Long-term Goals
Jun 30, 2025

Vitasoy International Holdings Limited has announced the grant of share options and performance share units to eligible participants under its 2022 Share Option Scheme and 2021 Share Award Scheme. The initiative aims to recognize past individual performance and align participants’ interests with the company’s long-term success. The grant includes 4,912,000 share options at an exercise price of HK$9.25 per share, with a vesting period of four years. The move is designed to attract and retain key employees, offering competitive compensation and driving strategic goals.

The most recent analyst rating on (HK:0345) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Vitasoy Announces Final Dividend for FY2025
Jun 24, 2025

Vitasoy International Holdings Limited announced a final ordinary cash dividend of HKD 0.102 per share for the financial year ending March 31, 2025. The dividend is set to be paid on September 17, 2025, following shareholder approval on August 25, 2025. This announcement reflects the company’s ongoing commitment to providing returns to its shareholders and may influence investor sentiment positively.

The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Vitasoy Proposes Amendments to Align with Regulatory Changes
Jun 24, 2025

Vitasoy International Holdings Limited has announced proposed amendments to its Articles of Association to align with recent changes in the Companies Ordinance and the Listing Rules in Hong Kong. These amendments aim to implement a treasury share regime and promote paperless corporate communications, reflecting the company’s adaptation to regulatory updates and its commitment to modernizing its corporate governance practices.

The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Vitasoy Reports Strong Profit Growth and Increased Dividends for FY2025
Jun 24, 2025

Vitasoy International Holdings reported a 1% increase in revenue to HK$6,274 million for the year ended 31st March 2025, driven by growth in Mainland China and strong performance in Hong Kong. The company’s gross profit margin improved to 51.3% due to lower commodity costs and enhanced manufacturing efficiency, although this was partially offset by higher trade promotional expenses and unfavorable foreign exchange movements. Profit attributable to equity shareholders surged by 102%, reflecting improved sales execution and operational efficiency. The company also announced a significant increase in dividends, proposing a total of HK14.2 cents per ordinary share for FY2024/2025, up from HK7.7 cents in the previous year.

The most recent analyst rating on (HK:0345) stock is a Buy with a HK$6.90 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Vitasoy Schedules Board Meeting to Approve Year-End Results and Dividend
Jun 11, 2025

Vitasoy International Holdings Limited has announced a board meeting scheduled for June 24, 2025, to approve the final results for the fiscal year ending March 31, 2025, and to consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.

The most recent analyst rating on (HK:0345) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Vitasoy Projects Significant Profit Growth for 2025
May 26, 2025

Vitasoy International Holdings has issued a positive profit alert, indicating a substantial increase in profit attributable to shareholders for the financial year ending March 31, 2025. The expected profit range is between HK$225 million and HK$245 million, marking a 94% to 111% increase from the previous year. This growth is driven by improved operations in Mainland China and Hong Kong SAR, as well as reduced losses in Australia, despite higher tax expenses.

The most recent analyst rating on (HK:0345) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 09, 2025